We address the challenge of leveraging complex lung transcriptomic data for nanosafety by re-optimizing the Transcriptomic Response Index (TRI) as a single, New Approach Methodology (NAM)-ready omics endpoint for instilled...
Muratov et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: